4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-23-025845
Options or other derivatives
- Director acquired 0 shares (option exercise)
- Director acquired 28,326 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pershing Edward Director | 2023-07-28 | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | D | |||
| Pershing Edward Director | 2023-07-28 | Option exercise · Series D-1 Convertible Preferred Stock | +28,326 | 563,891 | D | ||
Loading xslF345X05/ownership.xml…